{"frequencyBands":{"HP:0040280":[100,100],"HP:0040281":[80,99],"HP:0040282":[30,79],"HP:0040283":[5,29],"HP:0040284":[1,4],"HP:0040285":[0,0]},"page":{"anchorSlug":"alpha-n-acetylgalactosaminidase-deficiency-type-3","columns":[{"gene":"","key":"population-b626e2818c8ab494003a","label":"Alpha-N-acetylgalactosaminidase deficiency type 3","mondoId":"MONDO:0019264","onsetQualifier":null,"originColumnKey":"MONDO:0019264/ORPHA:79281","originalViews":[{"key":"MONDO:0019264/ORPHA:79281","label":"Alpha-N-acetylgalactosaminidase deficiency type 3","scopeLabel":"ORPHA:79281","sourceScope":"Native source population. Existing approved source identity; no family evidence is inherited."}],"recordKeys":["04097f27728f66f2dc096f3828cbd56c42719e4bcb0307c0d6df9adcb5dd5cad","04962f0b32c246fd94c27ba2771702f3e7ec096d10d77a86e6130bbdbeb168f3","1530ea91168c1dfaa7dcca5da8e11d7294ee3320f6496a7df608e1440a577707","29fe5d9a380170631892a40d677968fcb431676869b0931042e3b78dac70e589","3a2d616081519466d406399ce4fcd7e546a53043edba91db799566c8e65ee918","52e26b1a206a43c158f5ca499cb7b8e456847120bfe137c79311f6e097dc6e72","7fca3632473e7b7febc2f0a66e0ebaaa09cf1367f0e547ac73166fd374ecaf72","9ec6c72bea96d83b54787c536e19c1c74a788ff999ed86fb54ef5c0334c9e385"],"recordQualifiers":{},"scopeLabel":"ORPHA:79281","sourceIds":["ORPHA:79281"],"sourceScope":"Native source population. Existing approved source identity; no family evidence is inherited."}],"comparison":{"collapseColumnsLabel":"Show default populations","defaultColumnKeys":["population-b626e2818c8ab494003a"],"expandColumnsLabel":"Show all source populations","intro":"Features recorded for this MONDO node. Related-node evidence is available through separately scoped comparisons.","primaryFeatureIds":["HP:0000717","HP:0000518","HP:0001263","HP:0002240","HP:0001639","HP:0001249","HP:0001250"],"scopeNoteHtml":"<p>Each column retains its native condition identifier, assessed population and annotation references. Counts are not pooled.</p>"},"coverage":{"countRecords":0,"emptyColumnKeys":[],"hpoRelease":"2026-06-23","narrativeSourceChanges":[],"records":8,"sourceGroups":{"orphanet":8}},"features":[{"hpoId":"HP:0000717","label":"Autism","primary":true},{"hpoId":"HP:0000518","label":"Cataract","primary":true},{"hpoId":"HP:0001263","label":"Global developmental delay","primary":true},{"hpoId":"HP:0002240","label":"Hepatomegaly","primary":true},{"hpoId":"HP:0001639","label":"Hypertrophic cardiomyopathy","primary":true},{"hpoId":"HP:0001249","label":"Intellectual disability","primary":true},{"hpoId":"HP:0001250","label":"Seizure","primary":true},{"hpoId":"HP:0000486","label":"Strabismus","primary":false}],"ledeHtml":"Alpha-N-acetylgalactosaminidase deficiency type 3 is a rare disease that affects people in different ways. It can cause problems with development, the brain, and mental health. These symptoms usually appear when a person is in their middle years.","mondoId":"MONDO:0019264","node":{"canonicalSlug":"alpha-n-acetylgalactosaminidase-deficiency-type-3","comparisons":[{"documentSha256":"2facb2312f03bf0e989baa741e010b8bf29f85bb76065a9a8e7cdd299182b27a","key":"legacy-alpha-n-acetylgalactosaminidase-deficiency","kind":"legacy","label":"alpha-N-acetylgalactosaminidase deficiency","memberIds":["MONDO:0012221","MONDO:0012222","MONDO:0017779","MONDO:0019264"],"mondoId":"MONDO:0017779","url":"https://kcjyutqgtpgteszueluf.supabase.co/storage/v1/object/public/community-guides/learn-data/alpha-n-acetylgalactosaminidase-deficiency.2facb2312f03bf0e989baa741e010b8bf29f85bb76065a9a8e7cdd299182b27a.json"}],"contexts":[],"lifecycle":"active","narrative":{"causes":[],"contentForm":"summary","independentCorroborationEstablished":false,"matchMethod":"automatic-identity-and-attribution","name":"Alpha-N-acetylgalactosaminidase deficiency type 3","originalSourceId":"ORPHA:79281","paragraphs":["Alpha-N-acetylgalactosaminidase deficiency type 3 is a rare disease that affects people in different ways. It can cause problems with development, the brain, and mental health. These symptoms usually appear when a person is in their middle years."],"rawAttribution":"MONDO:0019264","reviewed":null,"scope":"exact","source":"GARD","sourceRelease":"2026-10-25T03:39:05Z","upstream":"PlainLanguagePilotV1-Sep23","url":"https://rarediseases.info.nih.gov/diseases/3903"},"ownColumnKeys":["population-b626e2818c8ab494003a"],"publication":"published","relationships":[{"kind":"parent","label":"alpha-N-acetylgalactosaminidase deficiency","mondoId":"MONDO:0017779","slug":"alpha-n-acetylgalactosaminidase-deficiency"}],"schemaVersion":1,"searchIndex":"/node-search/manifest.json","sourceHolds":{},"summaryHolds":[],"translation":"published"},"records":[{"frequencyKind":"range","key":"04097f27728f66f2dc096f3828cbd56c42719e4bcb0307c0d6df9adcb5dd5cad","raw":{"aspect":"P","body_system":"digestive","disease_id":"ORPHA:79281","disease_name":"Alpha-N-acetylgalactosaminidase deficiency type 3","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0002240","is_excluded":false,"label":"Hepatomegaly","onset_id":null,"reference":"ORPHA:79281","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"04962f0b32c246fd94c27ba2771702f3e7ec096d10d77a86e6130bbdbeb168f3","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:79281","disease_name":"Alpha-N-acetylgalactosaminidase deficiency type 3","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0001250","is_excluded":false,"label":"Seizure","onset_id":null,"reference":"ORPHA:79281","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"1530ea91168c1dfaa7dcca5da8e11d7294ee3320f6496a7df608e1440a577707","raw":{"aspect":"P","body_system":"eye","disease_id":"ORPHA:79281","disease_name":"Alpha-N-acetylgalactosaminidase deficiency type 3","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0000518","is_excluded":false,"label":"Cataract","onset_id":null,"reference":"ORPHA:79281","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"29fe5d9a380170631892a40d677968fcb431676869b0931042e3b78dac70e589","raw":{"aspect":"P","body_system":"cardiovascular","disease_id":"ORPHA:79281","disease_name":"Alpha-N-acetylgalactosaminidase deficiency type 3","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0001639","is_excluded":false,"label":"Hypertrophic cardiomyopathy","onset_id":null,"reference":"ORPHA:79281","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"3a2d616081519466d406399ce4fcd7e546a53043edba91db799566c8e65ee918","raw":{"aspect":"P","body_system":"eye","disease_id":"ORPHA:79281","disease_name":"Alpha-N-acetylgalactosaminidase deficiency type 3","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0000486","is_excluded":false,"label":"Strabismus","onset_id":null,"reference":"ORPHA:79281","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"52e26b1a206a43c158f5ca499cb7b8e456847120bfe137c79311f6e097dc6e72","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:79281","disease_name":"Alpha-N-acetylgalactosaminidase deficiency type 3","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0001249","is_excluded":false,"label":"Intellectual disability","onset_id":null,"reference":"ORPHA:79281","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"7fca3632473e7b7febc2f0a66e0ebaaa09cf1367f0e547ac73166fd374ecaf72","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:79281","disease_name":"Alpha-N-acetylgalactosaminidase deficiency type 3","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0001263","is_excluded":false,"label":"Global developmental delay","onset_id":null,"reference":"ORPHA:79281","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"9ec6c72bea96d83b54787c536e19c1c74a788ff999ed86fb54ef5c0334c9e385","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:79281","disease_name":"Alpha-N-acetylgalactosaminidase deficiency type 3","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0000717","is_excluded":false,"label":"Autism","onset_id":null,"reference":"ORPHA:79281","source_release":"2026-06-23"},"sourceGroups":["orphanet"]}],"referenceLabels":{},"references":{"causeHtml":"<p class=\"section-source\">Source: <a href=\"https://rarediseases.info.nih.gov/diseases/3903\" rel=\"noreferrer\">GARD</a></p><p class=\"section-source\">Source: <a href=\"https://monarchinitiative.org/MONDO:0019264\" rel=\"noreferrer\">MONDO</a></p><details class=\"deep-dive\"><summary>Narrative source and scope</summary><dl><dt>Content</dt><dd>summary</dd><dt>Scope</dt><dd>exact</dd><dt>Match method</dt><dd>automatic-identity-and-attribution</dd><dt>Upstream attribution</dt><dd>PlainLanguagePilotV1-Sep23</dd></dl></details>","identityNote":"MONDO identifies this node. Native source populations, annotation references and qualified comparison views retain their original scopes.","importantHtml":""},"sections":[{"bodyHtml":"<p>Alpha-N-acetylgalactosaminidase deficiency type 3 is a rare disease that affects people in different ways. It can cause problems with development, the brain, and mental health. These symptoms usually appear when a person is in their middle years.</p><p class=\"section-source\">Source: <a href=\"https://rarediseases.info.nih.gov/diseases/3903\" rel=\"noreferrer\">GARD</a></p>","key":"overview","title":"Overview"}],"sharedSources":[],"slug":"alpha-n-acetylgalactosaminidase-deficiency-type-3","sourceDocuments":[{"name":"GARD: Alpha-N-acetylgalactosaminidase deficiency type 3","reviewed":null,"source_release":"2026-10-25T03:39:05Z","url":"https://rarediseases.info.nih.gov/diseases/3903"},{"name":"MONDO: alpha-N-acetylgalactosaminidase deficiency type 3","reviewed":null,"source_release":"releases/2026-10-06","url":"https://monarchinitiative.org/MONDO:0019264"}],"sourceNote":"","synonyms":["NAGA deficiency type 3","Schindler disease type 3"],"takeawayHtml":"","title":"alpha-N-acetylgalactosaminidase deficiency type 3"},"schemaVersion":1}
